A number of studies has shown that long non-coding RNAs (lncRNAs), microRNAs
(miRNAs) and protein coding genes (PCGs) are involved in various pathophysiological …

Background Bladder cancer (BC) is a common malignancy neoplasm diagnosed in
advanced stages in most cases. It is crucial to screen ideal biomarkers and construct a more …

There is not a good biomaker that is closely related to survival time for bladder cancer
(BLCA), The aim of the study is to identify a miRNA signature that could predict prognosis in …

Background: The study aimed to find a potential long non-coding RNA (lncRNA) model
related to survival in bladder cancer by analyzing data in The Cancer Genome Atlas (TCGA) …

Background This study aimed to construct prognostic model by screening prognostic miRNA
signature of bladder cancer. Methods The miRNA expression profile data of bladder cancer …

BACKGROUND: Accumulating evidence shows that clinical factors alone are not adequate
for predicting the survival of patients with urothelial bladder cancer (UBC), and many genes …

Background Bladder cancer is a multifactorial disease with increasing incidence and
mortality. Genetic alterations and altered expressions of mRNAs, long non-coding RNAs …

Background Bladder cancer is one of the most common cancers, and its histopathological
type is mainly bladder urothelial carcinoma, accounting for about 90%. The prognostic …

Bladder cancer (BLCA) is one of the most common cancers worldwide with high recurrence
rate. Hence, we intended to establish a recurrence-related long non-coding RNA (lncRNA) …

Bladder cancer (BLCA) is one of the most malignant cancers worldwide, and its prognosis
varies. 1214 BLCA samples in five different datasets and 2 platforms were enrolled in this …